NanoViricides
NNVC
#10581
Rank
โ‚น2.78 B
Marketcap
โ‚น109.14
Share price
-1.68%
Change (1 day)
-12.53%
Change (1 year)

EPS for NanoViricides (NNVC)

EPS in 2026 (TTM): -โ‚น39.14

According to NanoViricides's latest financial reports the company's current EPS (TTM) is -โ‚น41.04. an increase over its 2025 EPS that were of -โ‚น58.77.

EPS history for NanoViricides from 2005 to 2026

Annual EPS

Year EPS Change
2026-โ‚น38.24-34.92%
2025-โ‚น58.77-10%
2024-โ‚น65.30-5.41%
2023-โ‚น69.035.71%
2022-โ‚น65.30-13.58%
2021-โ‚น75.56-66.11%
2020-โ‚น222.941.7%
2019-โ‚น219.21-10.98%
2018-โ‚น246.26-22.35%
2017-โ‚น317.15-10.53%
2016-โ‚น354.46375%
2015-โ‚น74.62-85.19%
2014-โ‚น503.7142.11%
2013-โ‚น354.4626.67%
2012-โ‚น279.84-6.25%
2011-โ‚น298.4914.28%
2010-โ‚น261.18100%
2009-โ‚น130.59-0%
2008-โ‚น130.59-33.33%
2007-โ‚น195.89-0%
2006-โ‚น195.894445.07%
2005-โ‚น4.31

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
-โ‚น289.17 604.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น92.63-325.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น421.63-1,127.27%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น268.40-753.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-โ‚น141.79 245.45%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚น125.93 206.82%๐Ÿ‡บ๐Ÿ‡ธ USA